A threesome so nice, we did it twice: talking $BMYRT with Matt and Dan (again)
Oct 08, 2020•42 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Our first threesome was such a success, we decided to do it again! Dan and Matt come back on to discuss all of the updates on the BMY CVR since our first post; in particular, we discuss Dan's due diligence that suggests an FDA inspection is on going.
PS- CVR's are risky and nothing on here is investing advice.
You can find our first threesome here: https://twitter.com/AndrewRangeley/status/1305835912975261697?s=20
My updated take on the CVR here: https://yetanothervalueblog.com/2020/10/bmy-cvr-an-inspection-inflection-bmyrt.html
Twitter handles:
Matt: Given2Tweet (https://twitter.com/given2tweet)
Dan: Sheep of Wall Street (https://twitter.com/Biohazard3737)
For the best experience, listen in Metacast app for iOS or Android